FIELD: medicine.
SUBSTANCE: group of inventions discloses a method for treatment of an individual suffering from cancer, comprising administration of isolated natural killer cells comprising isolated CD56+CD16-CD3- natural killer cells derived from placenta, a method for treating of an individual suffering from viral infection, comprising administration of isolated natural killer cells comprising isolated CD56+CD16-CD3-natural killer cells derived from placenta, and application of these cells to create a pharmaceutical composition.
EFFECT: efficacy of tumours and viral diseases treatment.
36 cl, 12 dwg, 20 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUPPRESSION OF TUMORS USING HUMAN PLACENTA DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATING COMPOUNDS | 2010 |
|
RU2742171C2 |
| TUMOUR SUPPRESSION WITH USE OF HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS RECOVERED FROM HUMAN PLACENTA | 2008 |
|
RU2536242C2 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS ISOLATED FROM HUMAN PLACENTA | 2008 |
|
RU2781543C2 |
| METHOD FOR EXPANSION OF HUMAN NK CELLS USING FEEDER CELLS | 2021 |
|
RU2781777C2 |
| IMPROVED CELL COMPOSITION AND METHODS OF OBTAINING THEREOF | 2009 |
|
RU2563518C2 |
| TREATMENT OF DISEASE, DISORDERS OR PATHOLOGICAL CONDITIONS OF LUNGS WITH APPLICATION OF PLACENTAL CELLS | 2009 |
|
RU2570550C2 |
| TREATING DISEASES, DISORDERS OR PATHOLOGICAL CONDITIONS OF THE LUNGS USING PLACENTAL CELLS | 2009 |
|
RU2732240C2 |
| IMPROVED CELL COMPOSITION AND METHODS FOR ITS PREPARATION | 2009 |
|
RU2662676C1 |
| STROKE TREATMENT WITH APPLICATION OF ISOLATED PLACENTAL CELLS | 2009 |
|
RU2558778C2 |
| UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE | 2019 |
|
RU2809113C2 |
